Kintara Therapeutics Inc reports results for the quarter ended in June - Earnings Summary

TuHURA Biosciences

27/09/2022 14:31

* Kintara Therapeutics Inc  KTRA.OQ  reported a quarterly
adjusted
loss of 11 cents​​ per share for the quarter ended in June. The
mean expectation of three analysts for the quarter was for a
loss of 3 cents per share.
    * Reported revenue was zero​; analysts expected zero. 
    * Kintara Therapeutics Inc's reported EPS for the quarter
was a
loss of 11 cents​.
    * The mean earnings estimate of analysts was unchanged in
the last
three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * Kintara Therapeutics Inc shares had fallen by 50.9% this
quarter and lost 73.3% so far this year.
    * The company reported a quarterly loss of $5.45 million.
    * Wall Street's median 12-month price target for Kintara
Therapeutics Inc is $3.00 
    * The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is no "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell." 

This summary was machine generated from Refinitiv data September
27 at 01:31 p.m.  ​All figures in US dollars unless otherwise
stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Jun. 30 2022      -0.03          -0.11          Missed
 Mar. 31 2022      -0.15          -0.11          Beat
 Dec. 31 2021      -0.16          -0.12          Beat
 Sep. 30 2021      -0.14          -0.17          Missed